Psagot Value Holdings’s Pulmonx LUNG Stock Holding History

Psagot Value Holdings’s Portfolio LUNG Stock Details LUNG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-331	Closed	-$4K	–	584
2023 Q1	$4K	Buy	+331	New	+$3.27K	﹤0.01%	362

Other funds holding LUNG

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

KXA

KPCB XIII Associates Menlo Park, California $186M AUM 11.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Psagot Value Holdings's LUNG Position: Q2 2023 in Review

Psagot Value Holdings sold out of Pulmonx (LUNG) in Q2 2023, closing a stake of 331 shares — an estimated $4K sold.

Psagot Value Holdings first reported a position in LUNG in Q1 2023 and held it in 1 quarter. The position peaked at $4K in Q1 2023. 115 funds tracked by Wall St. Rank hold LUNG as of Q2 2023.

Psagot Value Holdings reported no remaining Pulmonx position as of Q2 2023 after selling out during the quarter.
Psagot Value Holdings sold 331 Pulmonx shares in Q2 2023, an estimated $4K.
Psagot Value Holdings first reported a position in Pulmonx in Q1 2023 and held it in 1 quarter.
Psagot Value Holdings's Pulmonx position peaked at $4K in Q1 2023.
115 funds tracked by Wall St. Rank held Pulmonx as of Q2 2023.

Based on Psagot Value Holdings's 13F filing for Q2 2023, filed 3 Aug 2023.